Rapid report
Biomarker-based tests to support the decision for or against adjuvant systemic chemotherapy in primary breast cancer - state of knowledge
Report documents
-
Extract of the rapid report
Biomarker-based tests to support the decision for or against adjuvant systemic chemotherapy in primary breast cancer - state of knowledge
-
Rapid Report
Biomarker-based tests to support the decision for or against adjuvant systemic chemotherapy in primary breast cancer - state of knowledge
Press releases
Biomarker tests for decision-making on chemotherapy for breast cancer: No evidence of transferability
Tests assign different women to the group “low risk of recurrence”
Project details
- Project no.
- D19-01
- Commission
- Commission awarded on 11.07.2019 by the Federal Joint Committee (GBA).
- Report type
- Rapid report
- Status
- Commission completed
- Department/Division
- Non-Drug Interventions
- Topic
- Cancer
- Note
-
The rapid report was sent to the contracting agency (G-BA) on 18 February 2020 and published earlier than planned on 27 February 2020 at the request of the G-BA.